5AM Opportunities I, L.P.
Director at TRDA; 10% owner at ELVN; 10% owner at Pear Therapeutics, Inc.
- Sold, on record
- $4.7M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jul 9, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- TRDAEntrada Therapeutics, Inc.Director
- ELVNEnliven Therapeutics, Inc.10% owner
- Pear Therapeutics, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Pear Therapeutics, Inc.770,000 shares
- ELVN197,500 shares
- TRDA27,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Pear Therapeutics, Inc.UnusualSep 8, 2022 2022
Sold 770,000 shares at $2.05 ($1.6M)
5AM Opportunities I, L.P., 10% owner
Sold 57.7% of holdings ($2.7M position)563,562 shares leftFirst sale on recordFiling
- 2 Form 144 notice ELVNNoticeAug 24, 2023 +350 days
Filed to sell 72,876 shares ($1.2M)
5AM Opportunities I, L.P., Affiliate
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale ELVNNo planSep 26, 2023 +33 days
Sold 197,500 shares at $15.00 ($3M)
5AM Opportunities I, L.P., 10% owner
No 10b5-1 planSold 18.8% of holdings ($15.8M position)854,796 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice TRDANoticeJun 27, 2025 +640 days
Filed to sell 19,265 shares ($133k)
5AM Opportunities I, L.P., Director
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice TRDANoticeJun 30, 2025 +3 days
Filed to sell 6,422 shares ($44k)
5AM Opportunities I, L.P., Director
No 10b5-1 planFirst sale on recordFiling
- 6 Form 144 notice TRDANoticeJul 1, 2025 +1 day
Filed to sell 6,422 shares ($46k)
5AM Opportunities I, L.P., Director
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice TRDANoticeJul 9, 2025 +8 days
Filed to sell 6,935 shares ($52k)
5AM Opportunities I, L.P., Director
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale TRDANo planJul 9, 2025 same day
Sold 27,000 shares at $7.50 ($203k)
5AM Opportunities I, L.P., 10% owner
No 10b5-1 planSold 0.8% of holdings ($23.9M position)3.2M shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | Jul 11, 2025 | TRDA | 10% owner | Form 4 sale | 27,000 | $203k | 0.8% | No plan | SEC |
| Jul 9, 2025 | Jul 9, 2025 | TRDA | Director | Form 144 notice | 6,935 | $52k | Notice | SEC | |
| Jul 1, 2025 | Jul 1, 2025 | TRDA | Director | Form 144 notice | 6,422 | $46k | Notice | SEC | |
| Jun 30, 2025 | Jun 30, 2025 | TRDA | Director | Form 144 notice | 6,422 | $44k | Notice | SEC | |
| Jun 27, 2025 | Jun 27, 2025 | TRDA | Director | Form 144 notice | 19,265 | $133k | Notice | SEC | |
| Sep 26, 2023 | Sep 28, 2023 | ELVN | 10% owner | Form 4 sale | 197,500 | $3M | 18.8% | No plan | SEC |
| Aug 24, 2023 | Aug 24, 2023 | ELVN | Affiliate | Form 144 notice | 72,876 | $1.2M | Notice | SEC | |
| Sep 8, 2022 | Sep 8, 2022 | Pear Therapeutics, Inc. | 10% owner | Form 4 sale | 770,000 | $1.6M | 57.7% | Unusual | SEC |